Member Exclusive NEWS ROUND-UP

Cell therapy weekly: First stem cell drug application approved in China for Phase II clinical trial

This week: Gamida Cell (Jerusalem, Israel) and Be The Match BioTherapies (MN, USA) will collaborate to improve patient outcomes for those undergoing bone marrow transplants and Athersys (OH, USA) announces positive results from expletory clinical study of MultiStem® cell therapy.

Go to the profile of RegMedNet
Jan 24, 2019

Please sign in or register for FREE

No comments yet.